These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2576223)

  • 1. Müllerian inhibiting substance is present in testes of dogs with persistent müllerian duct syndrome.
    Meyers-Wallen VN; Donahoe PK; Ueno S; Manganaro TF; Patterson DF
    Biol Reprod; 1989 Nov; 41(5):881-8. PubMed ID: 2576223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.
    Meyers-Wallen VN; Lee MM; Manganaro TF; Kuroda T; Maclaughlin D; Donahoe PK
    Biol Reprod; 1993 Jun; 48(6):1410-8. PubMed ID: 8318594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Müllerian inhibiting substance in sex-reversed dogs.
    Meyers-Wallen VN; Donahoe PK; Manganaro T; Patterson DF
    Biol Reprod; 1987 Nov; 37(4):1015-22. PubMed ID: 3689844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen inhibition of Mullerian inhibiting substance in the chick embryo.
    Hutson JM; Ikawa H; Donahoe PK
    J Pediatr Surg; 1982 Dec; 17(6):953-9. PubMed ID: 6897657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical period for mullerian duct regression in the dog embryo.
    Meyers-Wallen VN; Manganaro TF; Kuroda T; Concannon PW; MacLaughlin DT; Donahoe PK
    Biol Reprod; 1991 Oct; 45(4):626-33. PubMed ID: 1751638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos.
    Meyers-Wallen VN; MacLaughlin D; Palmer V; Donahoe PK
    Mol Reprod Dev; 1994 Sep; 39(1):1-7. PubMed ID: 7999353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ontogeny of Mullerian inhibiting substance in the gonads of the chicken.
    Hutson J; Ikawa H; Donahoe PK
    J Pediatr Surg; 1981 Dec; 16(6):822-7. PubMed ID: 6896069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
    Weniger JP; Cate RL; Zeis A
    J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vivo roles of müllerian-inhibiting substance.
    Behringer RR
    Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The persistent müllerian duct syndrome with transverse testicular ectopia. A hypothesis on the role of müllerian inhibiting factor in the process of testicular migration].
    Asero L; Meli R
    Pediatr Med Chir; 1997; 19(3):223-5. PubMed ID: 9340616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the anti-müllerian hormone gene as cause of persistent müllerian duct syndrome.
    Lang-Muritano M; Biason-Lauber A; Gitzelmann C; Belville C; Picard Y; Schoenle EJ
    Eur J Pediatr; 2001 Nov; 160(11):652-4. PubMed ID: 11760020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
    Catlin EA; Tonnu VC; Ebb RG; Pacheco BA; Manganaro TF; Ezzell RM; Donahoe PK; Teixeira J
    Endocrinology; 1997 Feb; 138(2):790-6. PubMed ID: 9003016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mullerian inhibiting substance: a fetal hormone with surgical implications.
    Hutson JM; Donahoe PK; Budzik GP
    Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
    Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
    Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular localization of müllerian inhibiting substance in the developing rat ovary.
    Ueno S; Takahashi M; Manganaro TF; Ragin RC; Donahoe PK
    Endocrinology; 1989 Feb; 124(2):1000-6. PubMed ID: 2643506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent Mullerian duct syndrome in a Miniature Schnauzer dog with signs of feminization and a Sertoli cell tumour.
    Vegter AR; Kooistra HS; van Sluijs FJ; van Bruggen LW; Ijzer J; Zijlstra C; Okkens AC
    Reprod Domest Anim; 2010 Jun; 45(3):447-52. PubMed ID: 18954385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic adenosine 3',5'-monophosphate modulation of mullerian duct regression.
    Ikawa H; Hutson JM; Budzik GP; Donahoe PK
    Endocrinology; 1984 May; 114(5):1686-91. PubMed ID: 6201348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative change in fibronectin in cultured müllerian mesenchymal cells in response to diethylstilbestrol and müllerian-inhibiting substance.
    Teng CS
    Dev Biol; 1990 Jul; 140(1):1-7. PubMed ID: 2358110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.